AKT1 and polycystic ovary syndrome: Therefore, understanding the role of GCNT2 in modulating the PI3K/Akt pathway through glycosylation presents an exciting avenue for developing novel interventions aimed at alleviating the multifaceted challenges faced by women with PCOS (52).